<ul><li>Land area: 75,000 m²</li><li>Production: 8,000 m² </li><li>Pharmaceutical services: 2,400 m² </li><li>Analytics: 1,300 m² </li><li>Warehouse &amp; distribution: 8,300 m² </li><li>FTE: 430 </li><li>Shifts: 15/5</li></ul>

<ul><li>Production of Solids<ul><li>Powders and granules</li><li>Tablets</li><li>Film-coated tablets</li><li>Sugar-coated tablets</li></ul></li><li>OEB 1-3 </li><li>Quality services </li></ul>

<ul><li>Clinical trials manufacturing</li><li>Clinical trials packaging / distribution </li><li>Galenical development, scaling up </li><li>Development validation of analytical methods </li><li>Handling of narcotic drugs</li></ul>

<ul><li>Solid forms<ul><li>Blisters</li><li>Bottles</li></ul></li><li>Integrated serialization &amp; aggregation </li></ul>

<ul><li>Manufacturing licenses<ul><li>EU GMP </li></ul></li><li>Non EU-GMP certificates<ul><li>US FDA </li><li>ANVISA </li><li>Russian MoH</li><li>Libyan MoH</li><li>Japan MoH</li><li>Taiwan</li><li>United Arabian Emirates MoH</li><li>Yemen MoH</li></ul></li></ul>

Technologies

Manufacturing Solids
<ul><li>Granulation<ul><li>3 high shear mixers (100-600 l) </li><li>2 fluid bed dryers (250 kg)</li><li>1 drying ovens (200 kg)</li><li>1 roller compactor (100-200 kg/h)</li><li>4 container blenders (10-1000 kg)</li></ul></li><li>Compression - 6 rotary tablet presses:<ul><li>3 Fette 1200</li><li>1 Fette 2090</li><li>1 Fette 2200</li><li>1 Korsch XL400</li></ul></li></ul>
<ul><li>Coating<ul><li>1 drum coater (600 kg)</li><li>3 drum coater (200 – 300 kg)</li><li>6 coating pans (120 kg)</li></ul></li></ul>
Packaging 
<ul><li>Solid forms<ul><li>4 blister lines </li><li>1 bottle filling line</li></ul></li></ul>
Quality Control 
<ul><li>HPLC</li><li>GC</li><li>Photometer</li><li>Atomic absorption</li><li>RAMAN spectroscopy</li><li>FTIR spectroscopy</li><li>Polarimeter</li><li>Refractometer</li><li>Conductivity</li><li>TOC</li><li>Dissolution tester</li><li>Disintegration tester</li><li>Titration</li><li>Release equilibrium moisture</li><li>Microbiology lab</li><li>Germ identification</li><li>Stability chambers</li><li>Other technologies can be made available by cooperation with external laboratories</li></ul>

Products

<ul><li>Agents acting on the renin </li><li>All other therapeutic products </li><li>Analgesics </li><li>Antianemic preparations </li><li>Antibacterials for systemic use </li><li>Antidiarrheals, intestinal antiinflammatory / antiinfective agents </li><li>Antiepileptics </li><li>Antihistamines for systemic use </li><li>Antihypertensives </li><li>Anti-inflammatory and antirheumatic products </li><li>Anti-parkinson drugs </li><li>Antiprotozoals</li><li>Bile and liver therapy </li><li>Cardiac therapy </li><li>Cough and cold preparations </li><li>Drugs for functional gastrointestinal disorders </li><li>Gynecological antiinfectives and antiseptics </li><li>Laxatives </li><li>Mineral supplements </li><li>Other respiratory system products </li><li>Stomatological preparations </li><li>Urologicals </li><li>Vitamins</li></ul>

Gronau

The Aenova site in Gronau has special expertise in the development, production and packaging of tablets, suppositories and sterile liquids.

Gronau - Aenova Group

employees

certifications & approvals

square meter

Film Coater Aenova Gronau

Development Alzheimer Gronau Aenova

Exterior view Gronau Aenova

Facts

Location Gronau, Germany 
Competence center for conventional solids and clinical services

The Aenova site in Gronau has special expertise in the development, production and packaging of tablets, and is specialized in packaging and distribution of clinical trial material. The site can look back on more than 100 years of history in the field of pharmaceutical production and development. The Gronau site manufactures solid forms, packaged in blisters and bottles, and offers quality services such as analytical & microbiological testing; stability studies according to ICH guidelines, development and testing of packaging components, PQR as well as galenical & analytical development; manufacturing / packaging / distribution of clinical studies, handling of narcotics (approval).

Best pharmacist trainee in Lower Saxony completed her training at Aenova site in Gronau

14/11/2022 - Best pharmacist trainee has completed training at Aenova

Gronau, 14/11/2022

The best trainees in Lower Saxony were honored last week at the GOP Varieté Theater in Hanover: 110 young professionals completed their vocational training at IHK member companies this year with the grade "very good" and were recognized as the best in their training profession.
This includes a young trainee who completed her training at the Aenova site in Gronau. She was honored as the best pharmacist of the year.
Our young colleague not only performed excellently, but also completed her training in 2.5 years instead of the usual 3.5 years. She will be working in the laboratory at the site in the future. Congratulations on this first-class result!
At Aenova we attach great importance to the training of the younger generation and this task is very important to us. We train in the following professions at our sites:<ul><li>Pharmacist</li><li>Chemical laboratory technician</li><li>Industrial mechanic</li><li>Warehouse logistics specialist</li><li>Industrial clerk</li><li>Machine and plant operator</li><li>IT specialist for system integration</li></ul>
We take our responsibility for providing qualified vocational training for our junior staff very seriously. This top performance is also the result of the great commitment of the training company and the vocational school and illustrates the high quality of dual training.<figure><img src="https://www.aenova-group.com/content/_medium/B2022_BOM_TAB_Auszeichnung.jpg" data-image="555247" alt="Aenova Gronau IHK Ceremony"><figcaption>Best pharmacist trainee in Lower Saxony together with the training officer at the Aenova site in Gronau</figcaption></figure>

New Managing Director at the Aenova Site in Gronau

16/03/20221 - New Managing Director at the Aenova Site Gronau

Gronau, 16/03/2022

Welcome to Aenova: we would like to introduce our new Managing Director at the Gronau site, Dr. Frank Küpker.
Mr. Küpker looks back on a long career with well-known companies in the pharmaceutical industry. Mr. Küpker is a licensed pharmacist and has extensive experience in the production and technology of all common dosage forms.
Mr. Küpker follows Emil Wolf, who has changed to the Aenova site in Münster as Managing Director.
Within the Aenova network, the Gronau site stands out as Competence Center for freeze-dried sterile goods and conventional solids.
The Aenova site in Gronau has special expertise in the development, production and packaging of tablets, suppositories and sterile liquids.
The site can look back on more than 100 years of history in the field of pharmaceutical production and development.
The Gronau site manufactures solid forms, sterile forms, suppositories and rectal suspensions, packaged in blisters, bottles, ampoules and vials and offers quality services such as analytical & microbiological testing; stability studies according to ICH guidelines, development and testing of packaging components, PQR as well as galenical & analytical development; manufacturing / packaging / distribution of clinical studies, handling of narcotics (approval).

PR Aenova Gronau Sterile Filling Optical Control WP

Capacity increase of sterile production to 100 million ampoules and vials at Aenova's Gronau site

26/03/2021 - Capacity increase of sterile production to 100 million ampoules and vials

Gronau, 26.03.2021

<ul><li>Aenova starts up the new RABS filling line for ampoules from 1 ml to 5ml.</li><li>This is supplemented by fully automatic optical inspection and a new packaging line.</li><li>This will enable the Gronau site to produce around 100 million ampoules and vials per year. This corresponds to a capacity increase for sterile liquids of around 7%.</li></ul>
The production and filling of sterile products requires the highest level of safety and quality. Market demand for production capacity in the sterile field has also increased significantly in recent years and has been further boosted by the filling requirements of COVID19 vaccines. At its Gronau site, Aenova, a leading development service provider and contract manufacturer for the pharmaceutical and healthcare industries, has now significantly increased its ampoule capacities. With the new ampoule filling and closing line, the sixth sterile line at the Gronau site, a new fully automatic optical control line and a likewise new packaging line, a total of more than 100 million ampoules and vials can now be produced per year. Aenova's strategy is aimed at significantly expanding capacity and optimizing supply availability at several of the Group's sites.
Read more! 
<figure><img src="https://www.aenova-group.com/content/_medium/Aenova_cleaning_and_depyrogenation_ampoules_2.JPG" alt="New sterile filling line Aenova Gronau" /><figcaption>With the new sterile filling line, a total of 100 million ampoules and vials can be produced per year at Aenova in Gronau; here the cleaning and depyrogenation area. </figcaption></figure>

Haupt Pharma Wülfing modernizes the building for pharmaceutical development

Gronau, 03.08.2020

In pharmaceutical development and production, quality and safety are the central issues. This naturally also applies to buildings and their infrastructure. Haupt Pharma Wülfing GmbH, a member of the Aenova Group with over 4,300 employees worldwide and around 450 employees in Gronau, has now put the modernized development building back into operation.

Gronau

The Production Plant

Manufacturing Services

Development Services

Packaging Services

Certifications & Approvals

Product Types

Address

News